IP Verse

Nutritional Compositions And Infant Formulas Comprising A Mix Of Oligosaccharides And Optionally Bifidobacterium Lactis For Preventing, Treating Or Reducing The Severity Of Non-Rotavirus-Associated Diarrhoea - EP3493686

The patent EP3493686 was granted to Nestec on Mar 27, 2024. The application was originally filed on Jul 6, 2017 under application number EP17736937A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3493686

NESTEC
Application Number
EP17736937A
Filing Date
Jul 6, 2017
Status
Granted And Under Opposition
Feb 23, 2024
Publication Date
Mar 27, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FRIESLANDCAMPINA NEDERLANDJan 2, 2025FRIESLANDCAMPINA DEPARTMENTADMISSIBLE
NUTRICIADec 19, 2024NEDERLANDSCH OCTROOIBUREAUADMISSIBLE

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP2526784
DESCRIPTIONWO2004000004
DESCRIPTIONWO2006087391
DESCRIPTIONWO2012160080
INTERNATIONAL-SEARCH-REPORTUS2003072865
INTERNATIONAL-SEARCH-REPORTUS2009041736
INTERNATIONAL-SEARCH-REPORTUS2011064707
INTERNATIONAL-SEARCH-REPORTUS2012171166
INTERNATIONAL-SEARCH-REPORTUS2014255543
INTERNATIONAL-SEARCH-REPORTWO2015071402
INTERNATIONAL-SEARCH-REPORTWO2017021479
OPPOSITIONEP3331383
OPPOSITIONEP3389405
OPPOSITIONUS2003072865
OPPOSITIONUS2009041736
OPPOSITIONUS2012058094
OPPOSITIONWO2008116916
OPPOSITIONWO2012173486
OPPOSITIONWO2013057072
OPPOSITIONWO2015071402
OPPOSITIONWO2015091789
OPPOSITIONWO2016066460
OPPOSITIONWO2017021479
OPPOSITIONWO2017102705
OPPOSITIONWO2018024440

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- Chouraqui Jean-Pierre, Van Egroo Louis-Dominique, Fichot Marie-Claire, "Acidified milk formula supplemented with bifidobacterium lactis: Impact on infant diarrhea in residential care settings.", Journal of Pediatric Gastroenterology and Nutrition, Lippincott Williams Wilkins, Inc., US, US , (20040301), vol. 38, no. 3, doi:10.1097/00005176-200403000-00011, ISSN 0277-2116, pages 288 - 292, XP008104008
OPPOSITION- Manjiang Yao, Eric L. Lien, Maria R.Z. Capeding, Margaret Fitzgerald, Kalathur Ramanujam, Rebecca Yuhas, Robert Northington, Jowena Lebumfacil, Lin Wang, Patricia A. Derusso, "Effects of Term Infant Formulas Containing High sn-2 Palmitate With and Without Oligofructose on Stool Composition, Stool Characteristics, and Bifidogenicity", Journal of Pediatric Gastroenterology and Nutrition, Lippincott Williams Wilkins, Inc., US, US , (20141001), vol. 59, no. 4, doi:10.1097/MPG.0000000000000443, ISSN 0277-2116, pages 440 - 448, XP055349795
OPPOSITION- Sima Yaron, Dina Shachar, Lee Abramas, Arik Riskin, David Bader, Ita Litmanovitz, Fabiana Bar-Yoseph, Tzafra Cohen, Liora Levi, Yael Lifshitz, Raanan Shamir, Ron Shaoul, "Effect of High &bgr;-Palmitate Content in Infant Formula on the Intestinal Microbiota of Term Infants", Journal of Pediatric Gastroenterology and Nutrition, Lippincott Williams Wilkins, Inc., US, US , (20130401), vol. 56, no. 4, doi:10.1097/MPG.0b013e31827e1ee2, ISSN 0277-2116, pages 376 - 381, XP055345504
OPPOSITION- A Lucas, P Quinlan, S Abrams, S Ryan, S Meah, P J Lucas, "Randomised controlled trial of a synthetic triglyceride milk formula for preterm infants", ARCHIVES OF DISEASE IN CHILDHOOD. FETAL AND NEONATAL EDITION, BMJ PUBLISHING GROUP, LONDON, GB, GB , (19971101), vol. 77, no. 3, doi:10.1136/fn.77.3.F178, ISSN 1359-2998, pages F178 - F184, XP055561487
OPPOSITION- Dong Jin;Chen Chen;Lianqing Li;Shan Lu;Zhenjun Li;Zhemin Zhou;Huaiqi Jing;Yanmei Xu;Pengcheng Du;Haiyin Wang;Yanwen Xiong;Han Zheng;Xuemei Bai;Hui Sun;Lei Wang;Changyun Ye;Marcelo Gottschalk;Jianguo Xu, "Dynamics of fecal microbial communities in children with diarrhea of unknown etiology and genomic analysis of associated Streptococcus lutetiensis", BMC MICROBIOLOGY, BioMed Central Ltd., GB, GB , (20130619), vol. 13, no. 1, doi:10.1186/1471-2180-13-141, ISSN 1471-2180, page 141, XP021156190
OPPOSITION- Turroni Francesca, Peano Clelia, Pass Daniel A., Foroni Elena, Severgnini Marco, Claesson Marcus J., Kerr Colm, Hourihane Jonathan, Murray Deirdre, Fuligni Fabio, Gueimonde Miguel, Margolles Abelardo, De Bellis Gianluca, O’toole Paul W., Van Sinderen Douwe, Marchesi Julian R., Ventura Marco, "Diversity of Bifidobacteria within the Infant Gut Microbiota", PLoS ONE, (20120501), vol. 7, no. 5, doi:10.1371/journal.pone.0036957, page e36957, XP055894517
OPPOSITION- Sanders Thomas Ab, Filippou Androulla, Berry Sarah E, Baumgartner Sabine, Mensink Ronald P, "Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism", American Journal of Clinical Nutrition, Elsevier, (20111201), vol. 94, no. 6, doi:10.3945/ajcn.111.017459, ISSN 0002-9165, pages 1433 - 1441, XP093251631
OPPOSITION- Baglatzi L., Gavrili S., Stamouli K., Zachaki S., Favre L., Pecquet S., Benyacoub J., Costalos C., "Effect of Infant Formula Containing a Low Dose of the Probiotic Bifidobacterium lactis CNCM I-3446 on Immune and Gut Functions in C-Section Delivered Babies: A Pilot Study", Clinical Medicine Insights: Pediatrics, (20160101), vol. 10, doi:10.4137/CMPed.S33096, ISSN 1179-5565, page CMPed.S33096, XP055886484

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents